Chemicals - Specialty
Compare Stocks
2 / 10Stock Comparison
GEVO vs REX
Revenue, margins, valuation, and 5-year total return — side by side.
Chemicals - Specialty
GEVO vs REX — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Chemicals - Specialty | Chemicals - Specialty |
| Market Cap | $497M | $1.58B |
| Revenue (TTM) | $161M | $651M |
| Net Income (TTM) | $1M | $50M |
| Gross Margin | 49.9% | 12.7% |
| Operating Margin | -12.5% | 8.6% |
| Forward P/E | — | 62.0x |
| Total Debt | $3M | $21M |
| Cash & Equiv. | $1M | $196M |
GEVO vs REX — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Gevo, Inc. (GEVO) | 100 | 158.9 | +58.9% |
| REX American Resour… (REX) | 100 | 491.5 | +391.5% |
Price return only. Dividends and distributions are not included.
Quick Verdict: GEVO vs REX
Each card shows where this stock fits in a portfolio — not just who wins on paper.
GEVO is the clearest fit if your priority is growth exposure.
- Rev growth 8.5%, EPS growth 58.8%, 3Y rev CAGR 415.1%
- 8.5% revenue growth vs REX's -22.9%
REX carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.
- beta 0.36
- 448.8% 10Y total return vs GEVO's -98.4%
- Lower volatility, beta 0.36, Low D/E 3.3%, current ratio 8.64x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 8.5% revenue growth vs REX's -22.9% | |
| Quality / Margins | 7.7% margin vs GEVO's 0.8% | |
| Stability / Safety | Beta 0.36 vs GEVO's 1.64 | |
| Dividends | Tie | Neither stock pays a meaningful dividend |
| Momentum (1Y) | +141.8% vs GEVO's +101.0% | |
| Efficiency (ROA) | 6.7% ROA vs GEVO's 0.2%, ROIC 11.4% vs -3.6% |
GEVO vs REX — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
GEVO vs REX — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
Evenly matched — GEVO and REX each lead in 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
REX is the larger business by revenue, generating $651M annually — 4.1x GEVO's $161M. REX is the more profitable business, keeping 7.7% of every revenue dollar as net income compared to GEVO's 0.8%. On growth, GEVO holds the edge at +7.0% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $161M | $651M |
| EBITDAEarnings before interest/tax | $5M | $67M |
| Net IncomeAfter-tax profit | $1M | $50M |
| Free Cash FlowCash after capex | -$43M | $18M |
| Gross MarginGross profit ÷ Revenue | +49.9% | +12.7% |
| Operating MarginEBIT ÷ Revenue | -12.5% | +8.6% |
| Net MarginNet income ÷ Revenue | +0.8% | +7.7% |
| FCF MarginFCF ÷ Revenue | -27.0% | +2.7% |
| Rev. Growth (YoY)Latest quarter vs prior year | +7.0% | +0.4% |
| EPS Growth (YoY)Latest quarter vs prior year | +66.8% | +2.9% |
Valuation Metrics
Evenly matched — GEVO and REX each lead in 2 of 4 comparable metrics.
Valuation Metrics
On an enterprise value basis, REX's 16.3x EV/EBITDA is more attractive than GEVO's 97.6x.
| Metric | ||
|---|---|---|
| Market CapShares × price | $497M | $1.6B |
| Enterprise ValueMkt cap + debt − cash | $499M | $1.4B |
| Trailing P/EPrice ÷ TTM EPS | -14.64x | 29.10x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 61.96x |
| PEG RatioP/E ÷ EPS growth rate | — | 0.55x |
| EV / EBITDAEnterprise value multiple | 97.58x | 16.35x |
| Price / SalesMarket cap ÷ Revenue | 3.10x | 2.46x |
| Price / BookPrice ÷ Book value/share | 1.02x | 2.63x |
| Price / FCFMarket cap ÷ FCF | — | — |
Profitability & Efficiency
REX leads this category, winning 6 of 8 comparable metrics.
Profitability & Efficiency
REX delivers a 7.7% return on equity — every $100 of shareholder capital generates $8 in annual profit, vs $0 for GEVO. GEVO carries lower financial leverage with a 0.01x debt-to-equity ratio, signaling a more conservative balance sheet compared to REX's 0.03x. On the Piotroski fundamental quality scale (0–9), REX scores 5/9 vs GEVO's 2/9, reflecting solid financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +0.3% | +7.7% |
| ROA (TTM)Return on assets | +0.2% | +6.7% |
| ROICReturn on invested capital | -3.6% | +11.4% |
| ROCEReturn on capital employed | -9.0% | +10.1% |
| Piotroski ScoreFundamental quality 0–9 | 2 | 5 |
| Debt / EquityFinancial leverage | 0.01x | 0.03x |
| Net DebtTotal debt minus cash | $2M | -$175M |
| Cash & Equiv.Liquid assets | $1M | $196M |
| Total DebtShort + long-term debt | $3M | $21M |
| Interest CoverageEBIT ÷ Interest expense | -0.59x | — |
Total Returns (Dividends Reinvested)
REX leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in REX five years ago would be worth $35,231 today (with dividends reinvested), compared to $3,516 for GEVO. Over the past 12 months, REX leads with a +141.8% total return vs GEVO's +101.0%. The 3-year compound annual growth rate (CAGR) favors REX at 50.1% vs GEVO's 18.6% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -0.5% | +48.2% |
| 1-Year ReturnPast 12 months | +101.0% | +141.8% |
| 3-Year ReturnCumulative with dividends | +66.7% | +238.4% |
| 5-Year ReturnCumulative with dividends | -64.8% | +252.3% |
| 10-Year ReturnCumulative with dividends | -98.4% | +448.8% |
| CAGR (3Y)Annualised 3-year return | +18.6% | +50.1% |
Risk & Volatility
REX leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
REX is the less volatile stock with a 0.36 beta — it tends to amplify market swings less than GEVO's 1.64 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. REX currently trades 90.0% from its 52-week high vs GEVO's 69.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.64x | 0.36x |
| 52-Week HighHighest price in past year | $2.97 | $53.36 |
| 52-Week LowLowest price in past year | $1.01 | $19.44 |
| % of 52W HighCurrent price vs 52-week peak | +69.0% | +90.0% |
| RSI (14)Momentum oscillator 0–100 | 56.2 | 79.2 |
| Avg Volume (50D)Average daily shares traded | 4.4M | 203K |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Wall Street rates GEVO as "Buy" and REX as "Buy". Consensus price targets imply 70.7% upside for GEVO (target: $4) vs 24.9% for REX (target: $60).
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $3.50 | $60.00 |
| # AnalystsCovering analysts | 14 | 3 |
| Dividend YieldAnnual dividend ÷ price | — | — |
| Dividend StreakConsecutive years of raises | — | — |
| Dividend / ShareAnnual DPS | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +0.9% |
REX leads in 3 of 6 categories — strongest in Profitability & Efficiency and Total Returns. 2 categories are tied.
GEVO vs REX: Frequently Asked Questions
9 questions · data-driven answers · updated daily
01Is GEVO or REX a better buy right now?
For growth investors, Gevo, Inc.
(GEVO) is the stronger pick with 849. 3% revenue growth year-over-year, versus -22. 9% for REX American Resources Corporation (REX). REX American Resources Corporation (REX) offers the better valuation at 29. 1x trailing P/E (62. 0x forward), making it the more compelling value choice. Analysts rate Gevo, Inc. (GEVO) a "Buy" — based on 14 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — GEVO or REX?
Over the past 5 years, REX American Resources Corporation (REX) delivered a total return of +252.
3%, compared to -64. 8% for Gevo, Inc. (GEVO). Over 10 years, the gap is even starker: REX returned +448. 8% versus GEVO's -98. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — GEVO or REX?
By beta (market sensitivity over 5 years), REX American Resources Corporation (REX) is the lower-risk stock at 0.
36β versus Gevo, Inc. 's 1. 64β — meaning GEVO is approximately 352% more volatile than REX relative to the S&P 500. On balance sheet safety, Gevo, Inc. (GEVO) carries a lower debt/equity ratio of 1% versus 3% for REX American Resources Corporation — giving it more financial flexibility in a downturn.
04Which is growing faster — GEVO or REX?
By revenue growth (latest reported year), Gevo, Inc.
(GEVO) is pulling ahead at 849. 3% versus -22. 9% for REX American Resources Corporation (REX). On earnings-per-share growth, the picture is similar: Gevo, Inc. grew EPS 58. 8% year-over-year, compared to -4. 9% for REX American Resources Corporation. Over a 3-year CAGR, GEVO leads at 415. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — GEVO or REX?
REX American Resources Corporation (REX) is the more profitable company, earning 9.
1% net margin versus 0. 8% for Gevo, Inc. — meaning it keeps 9. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: REX leads at 10. 0% versus -12. 6% for GEVO. At the gross margin level — before operating expenses — GEVO leads at 49. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Is GEVO or REX more undervalued right now?
Analyst consensus price targets imply the most upside for GEVO: 70.
7% to $3. 50.
07Which pays a better dividend — GEVO or REX?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
08Is GEVO or REX better for a retirement portfolio?
For long-horizon retirement investors, REX American Resources Corporation (REX) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
36), +448. 8% 10Y return). Gevo, Inc. (GEVO) carries a higher beta of 1. 64 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (REX: +448. 8%, GEVO: -98. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
09What are the main differences between GEVO and REX?
Both stocks operate in the Basic Materials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: GEVO is a small-cap high-growth stock; REX is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.